Minerva Neurosciences enters equity distribution deal for up to $75 million ATM offering

• Minerva Neurosciences set up an at-the-market equity offering program for up to USD 75 million of common stock.
• Leerink Partners will act as sales agent, earning a 3% commission on gross proceeds from any shares sold.
• Sales can occur from time to time under a shelf registration statement on Form S-3 that became effective March 19, 2026.
• The company can pause sales or terminate the sales agreement at its discretion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Minerva Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-241930), on May 27, 2026, and is solely responsible for the information contained therein.